Skip to main content

Galmeon

Galmeon provides a neuromotor therapy that targets and lifts pathological motor inhibitions—a neurological block preventing full muscle activation after injury or surgery. The Galmeon Wave medical device delivers a specific treatment protocol administered by certified practitioners, with published clinical evidence showing significant functional knee gains after a single one-hour session. The company also offers the Galmeon Elite program for sports institutions focused on accelerated re-athletization and injury prevention.

Traction 10/10
Lyon, France · HQ
Founded 20258500+ followers
  • Medical Devices
  • Healthcare Technology
  • Hardware
  • Sports Technology
  • Wellness & Fitness Technology
Updated 7 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

After musculoskeletal injury or surgery, patients often experience persistent motor inhibition—a neurological block that prevents full muscle activation and delays functional recovery. Standard rehabilitation approaches frequently fail to address this underlying neural component, prolonging recovery times and limiting return to pre-injury performance levels.

Solution

Galmeon offers a neuromotor therapy that targets and lifts pathological motor inhibitions to restore optimal motor function. The Galmeon Wave medical device delivers a specific treatment protocol that reactivates inhibited muscle pathways, enabling faster and more complete recovery. The therapy is applied by certified practitioners across multiple indications including orthopedic, neurological, and maxillo-facial conditions. For elite athletes, the Galmeon Elite program accelerates re-athletization, optimizes performance, and reduces injury risk through dedicated protocols including performance-focused imaging, injury prevention, and technical optimization. Clinical evidence published in the journal Sports Health demonstrates significant functional knee gains and increased Vastus Medialis Oblique activation after a single one-hour session, with over 15,000 patients treated to date.

Target Audience

Primary customers are healthcare practitioners including physiotherapists, osteopaths, physicians, and surgeons, as well as sports institutions and elite athletes seeking accelerated recovery and performance optimization.

Features

  • Galmeon Wave medical device delivering targeted neuromotor stimulation to lift pathological motor inhibitions
  • Published clinical study in Sports Health showing 93% functional knee gains and 79% increased Vastus Medialis Oblique activation after one session
  • Certified practitioner network with specialized training programs for physiotherapists, osteopaths, physicians, and surgeons
  • Galmeon Elite program for sports institutions featuring performance-focused imaging protocols, injury prevention, and technical optimization
  • Coverage of multiple indications including knee, ankle, hip, shoulder, hand, elbow, spine, neurological conditions, and maxillo-facial disorders
  • Galmeon Care program covering pre-operative surgical potentiation and return-to-play protocols
This profile is AI-generated and may contain inaccuracies.